2022 Q1 Form 10-Q Financial Statement
#000164033422000354 Filed on February 18, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $53.71K | $38.27K | $0.00 |
YoY Change | 4490.6% | ||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $53.71K | $38.27K | $0.00 |
YoY Change | 4490.6% | -98.39% | |
Operating Profit | -$53.71K | -$38.27K | |
YoY Change | -98.39% | ||
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | ||
YoY Change | |||
Pretax Income | -$53.71K | -$38.27K | $0.00 |
YoY Change | 4490.6% | -98.39% | |
Income Tax | $0.00 | $0.00 | |
% Of Pretax Income | |||
Net Earnings | -$53.71K | -$38.27K | $0.00 |
YoY Change | 4490.6% | -98.39% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.03 | -$0.02 | |
Diluted Earnings Per Share | -$33.10K | -$23.59K | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 162.3M shares | 1.623M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q1 | 2021 Q4 | 2021 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $0.00 | ||
YoY Change | |||
Cash & Equivalents | $0.00 | $0.00 | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $0.00 | |
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $0.00 | $0.00 | |
Total Long-Term Assets | $0.00 | $0.00 | |
Total Assets | $0.00 | ||
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.190K | ||
YoY Change | |||
Accrued Expenses | $26.65K | ||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $91.98K | $38.27K | |
YoY Change | 228.73% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $91.98K | $38.27K | |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $91.98K | $38.27K | |
YoY Change | 228.73% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$2.575M | -$2.536M | |
YoY Change | |||
Common Stock | $2.535M | $2.535M | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$91.98K | -$38.27K | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $0.00 | ||
YoY Change |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$53.71K | -$38.27K | $0.00 |
YoY Change | 4490.6% | -98.39% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$29.26K | -$36.07K | $0.00 |
YoY Change | 451.04% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 29.26K | $36.07K | 0.000 |
YoY Change | 451.04% | 770.93% | |
NET CHANGE | |||
Cash From Operating Activities | -29.26K | -36.07K | 0.000 |
Cash From Investing Activities | |||
Cash From Financing Activities | 29.26K | $36.07K | 0.000 |
Net Change In Cash | 0.000 | $36.07K | 0.000 |
YoY Change | 770.93% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | -$29.26K | -$36.07K | $0.00 |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
162255000 | shares |
CY2021Q4 | us-gaap |
Cash
Cash
|
0 | USD |
CY2021Q3 | us-gaap |
Cash
Cash
|
0 | USD |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
0 | USD |
CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
0 | USD |
CY2021Q4 | us-gaap |
Assets
Assets
|
0 | USD |
CY2021Q3 | us-gaap |
Assets
Assets
|
0 | USD |
CY2021Q4 | us-gaap |
Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
|
2191 | USD |
CY2021Q3 | us-gaap |
Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
|
0 | USD |
CY2021Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
36074 | USD |
CY2021Q3 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
0 | USD |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
38265 | USD |
CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
0 | USD |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
38265 | USD |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
0 | USD |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1000 | USD |
CY2021Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1000 | USD |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
16226 | USD |
CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
16226 | USD |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2519102 | USD |
CY2021Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2519102 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2574593 | USD |
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2536328 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-38265 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | USD |
CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | USD |
CY2021Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2020Q4 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2021Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
734 | USD |
CY2020Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
300 | USD |
CY2021Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
37531 | USD |
CY2020Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
3843 | USD |
CY2021Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | USD |
CY2020Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2369070 | USD |
CY2021Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
38265 | USD |
CY2020Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
2373213 | USD |
CY2021Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-38265 | USD |
CY2020Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2373213 | USD |
CY2021Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-38265 | USD |
CY2020Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2373213 | USD |
CY2021Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2020Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2021Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-38265 | USD |
CY2020Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2373213 | USD |
CY2021Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
CY2020Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2021Q4 | us-gaap |
Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
|
162255000 | shares |
CY2020Q4 | us-gaap |
Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
|
161637609 | shares |
CY2021Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-38265 | USD |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-38265 | USD |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-22669 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2020Q4 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2369070 | USD |
CY2020Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2373213 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-26812 | USD |
CY2021Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-38265 | USD |
CY2020Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2373213 | USD |
CY2021Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | USD |
CY2020Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2369070 | USD |
CY2021Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2191 | USD |
CY2020Q4 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
0 | USD |
CY2021Q4 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-36074 | USD |
CY2020Q4 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-4142 | USD |
CY2021Q4 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
36074 | USD |
CY2020Q4 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
4142 | USD |
CY2021Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
36074 | USD |
CY2020Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4142 | USD |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | USD |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2020Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2021Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
CY2020Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
CY2021Q4 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2020Q4 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2021Q4 | pglo |
Working Capital
WorkingCapital
|
38265 | USD |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2574593 | USD |
CY2021Q4 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> |